AC005392.2 is detected to be positively correlated with SOX2 and VM marker EPHA2 in CRC, and patients with high levels of AC005392.2 and SOX2 or EPHA2 have a worse prognosis than those with low expression. This evidence concerns the gene EPHA2 and colorectal carcinoma.